7 months ago
IBRX
AnalystsAndres Y. MaldonadoAndres Y. Maldonado's Stock Forecasts
AnalystsAndres Y. Maldonado
Sectors:
Industries:
Analyst Ranking
Top 8%
#405 out of 5511 analysts
Average Return
+26.75%
Win Rate
54%45 out of 83
Risk vs Reward
Poor
Good
Andres Y. Maldonado's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +245.99% | $32.03 | $110.82 | 2025-08-26 - 2026-08-25 | Buy |
Immunitybio IncIBRX | +243.64% | $2.36 | $8.11 | 2025-05-12 - 2026-05-11 | Buy |
Immunitybio IncIBRX | +213.71% | $2.48 | $7.78 | 2025-04-16 - 2026-04-15 | Buy |
Immunitybio IncIBRX | +213.62% | $2.57 | $8.06 | 2025-09-10 - 2026-09-09 | Buy |
Terns Pharmaceuticals IncTERN | +203.27% | $17.43 | $52.86 | 2025-11-04 - 2026-03-25 | Buy |
Andres Y. Maldonado Analyst Color
Get additional color on Andres Y. Maldonado's coverage of popular stocks
Andres Y. Maldonado's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | 7 | Buy | $70.00 | +40.00% | Maintains | 2 days ago |
Corbus Pharmaceuticals Holdings IncCRBP | 5 | Buy | $35.00 | +405.78% | Reiterates | 2 days ago |
Verastem IncVSTM | 4 | Buy | $18.00 | +145.23% | Reiterates | 5 days ago |
Immunome IncIMNM | 3 | Buy | $40.00 | +67.01% | Reiterates | 6 days ago |
Engene Therapeutics IncENGN | 6 | Buy | $4.00 | +111.64% | Reiterates | 8 days ago |
Tscan Therapeutics IncTCRX | 3 | Hold | $1.00 | +211.53% | Downgrades | 8 days ago |
Novabridge BiosciencesNBP | 5 | Buy | $9.00 | +466.04% | Reiterates | a month ago |
Candel Therapeutics IncCADL | 2 | Buy | $23.00 | +106.83% | Reiterates | a month ago |
Erasca IncERAS | 4 | Buy | $22.00 | +35.38% | Maintains | a month ago |
Aura Biosciences IncAURA | 3 | Buy | $18.00 | +160.12% | Maintains | a month ago |
Immuneering CorpIMRX | 1 | Buy | $14.00 | +215.32% | Initiates Coverage On | a month ago |
Syndax Pharmaceuticals IncSNDX | 6 | Buy | $38.00 | +110.06% | Maintains | a month ago |
Monopar TherapeuticsMNPR | 4 | Buy | $125.00 | +19.81% | Maintains | 2 months ago |
Relmada Therapeutics IncRLMD | 1 | Buy | $12.00 | +170.27% | Initiates Coverage On | 3 months ago |
Immunitybio IncIBRX | 11 | Buy | $15.00 | +84.28% | Reiterates | 3 months ago |
Cg Oncology IncCGON | 7 | Buy | $100.00 | +37.84% | Reiterates | 4 months ago |
Sutro Biopharma IncSTRO | 3 | Buy | $50.00 | +201.93% | Maintains | 4 months ago |
Terns Pharmaceuticals IncTERN | 3 | Hold | $53.00 | +0.09% | Downgrades | 6 months ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $13.00 | +215.53% | Reiterates | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 3 | Hold | $21.50 | -0.14% | Downgrades | 6 months ago |
Protara Therapeutics IncTARA | 3 | Buy | $23.00 | +513.33% | Reiterates | 7 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $4.00 | +308.16% | Maintains | 9 months ago |
Merus NvMRUS | 1 | Hold | $97.00 | +7.78% | Downgrades | a year ago |
Keros Therapeutics IncKROS | 1 | Buy | $20.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.